The ABO Locus is Associated with Increased Fibrin Network Formation in Patients with Stable Coronary Artery Disease

Anne Winther-Larsen1,2, Morten Krogh Christiansen3, Sanne Bøjet Larsen3

  • 1Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.

Insights

The ABO risk allele is linked to denser fibrin clots in coronary artery disease (CAD) patients, potentially explaining increased myocardial infarction (MI) risk. This study investigated ABO variants and fibrin clot properties in CAD.

Area of Science:

  • Cardiovascular Genetics
  • Thrombosis and Hemostasis
  • Molecular Cardiology

Background:

  • The ABO locus is associated with myocardial infarction (MI) risk in coronary artery disease (CAD) patients, but mechanisms remain unclear.
  • Altered fibrin clot structure is a known predictor of MI in CAD patients.
  • This study investigates the link between ABO risk variants and fibrin clot properties.

Purpose of the Study:

  • To examine the association between the ABO risk variant and fibrin clot properties in stable CAD patients.
  • To investigate the effects of other CAD-associated risk variants on fibrin clot properties.

Main Methods:

  • Genotyping of 773 stable CAD patients for 45 genome-wide CAD risk variants, including the ABO locus variant rs495828.
  • Calculation of a CAD genetic risk score (GRS) based on risk alleles.
  • Evaluation of fibrin clot properties, including maximum absorbance (clot density/fiber thickness) and clot lysis time, using turbidimetric assays.

Main Results:

  • The rs495828 risk allele was associated with significantly higher clot maximum absorbance (p=0.01), indicating a denser clot.
  • No significant association was found between the ABO risk allele and clot lysis time (p=0.97).
  • None of the other 44 CAD variants or the overall GRS showed significant associations with fibrin clot properties after Bonferroni correction.

Conclusions:

  • The ABO risk allele is associated with a more compact fibrin network in stable CAD patients.
  • This altered fibrin structure may represent a key mechanism contributing to the increased MI risk observed in carriers of ABO risk variants.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
267
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
281
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
767
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
229
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.1K